
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
来源:CNBC发布于 2026-08-05
Bank of America CEO Brian Moynihan said the company is spending more than $250 million annually to provide GLP-1 weight loss medications to its workforce. Moynihan told CNBC the expense has surged fro...
相关标的:BAC
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。